FDA Approved: SUNITINIB MALATE — Original Application (Mylan Pharmaceuticals Inc.)

View source ↗

Summary

FDA approved a generic version of sunitinib malate submitted by Mylan Pharmaceuticals Inc., for use in cancer indications shared with the reference product. The…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastrointestinal Stromal Tumor
• Pancreatic Neuroendocrine Tumor
• Renal Cell Carcinoma

Drugs mentioned

• Sunitinib malate (sunitinib malate)

Snippet

ORIG AP for SUNITINIB MALATE (SUNITINIB MALATE)